These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36972033)

  • 21. Glucocorticoids in the treatment of severe sepsis and septic shock.
    Annane D
    Curr Opin Crit Care; 2005 Oct; 11(5):449-53. PubMed ID: 16175031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoids with or without fludrocortisone in septic shock: a narrative review from a biochemical and molecular perspective.
    Nethathe GD; Lipman J; Anderson R; Fuller PJ; Feldman C
    Br J Anaesth; 2024 Jan; 132(1):53-65. PubMed ID: 38030548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of hydrocortisone versus hydrocortisone plus fludrocortisone on duration of shock: A propensity score-weighted analysis.
    John KE; Kirkpatrick MM; Aytoda PH; Elefritz JL; Palettas M; Rosales BN; Murphy CV; Doepker BA
    Int J Crit Illn Inj Sci; 2024; 14(2):79-85. PubMed ID: 39005974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should We Add Fludrocortisone to Hydrocortisone for Treatment of Septic Shock?
    Matthay MA; Dahabreh IJ; Thompson BT
    JAMA Intern Med; 2023 May; 183(5):460-461. PubMed ID: 36972044
    [No Abstract]   [Full Text] [Related]  

  • 25. In septic shock and CAP, hydrocortisone + fludrocortisone reduced 90-d mortality.
    Maki DG
    Ann Intern Med; 2024 Jun; 177(6):JC62. PubMed ID: 38830222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External Corroboration That Corticosteroids May Be Harmful to Septic Shock Endotype A Patients.
    Wong HR; Hart KW; Lindsell CJ; Sweeney TE
    Crit Care Med; 2021 Jan; 49(1):e98-e101. PubMed ID: 33156120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome.
    Annane D; Sébille V; Bellissant E;
    Crit Care Med; 2006 Jan; 34(1):22-30. PubMed ID: 16374152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fludrocortisone dose-response relationship in septic shock: a randomised phase II trial.
    Walsham J; Hammond N; Blumenthal A; Cohen J; Myburgh J; Finfer S; Evans D; Peake S; Kruger P; McCullough J; Johnk L; Ghelani D; Billot L; Shan S; Meyer J; Rajbhandari D; Koch C; Bellomo R; Burrell LM; Young M; Roberts M; Mackenzie L; Medley G; Dalton J; Venkatesh B
    Intensive Care Med; 2024 Dec; 50(12):2050-2060. PubMed ID: 39235623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low doses of fludrocortisone and hydrocortisone, alone or in combination, on vascular responsiveness to phenylephrine in healthy volunteers.
    Laviolle B; Donal E; Le Maguet P; Lainé F; Bellissant E
    Br J Clin Pharmacol; 2013 Feb; 75(2):423-30. PubMed ID: 22703532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human activated protein C for adults with septic shock: a randomized controlled trial.
    Annane D; Timsit JF; Megarbane B; Martin C; Misset B; Mourvillier B; Siami S; Chagnon JL; Constantin JM; Petitpas F; Souweine B; Amathieu R; Forceville X; Charpentier C; Tesnière A; Chastre J; Bohe J; Colin G; Cariou A; Renault A; Brun-Buisson C; Bellissant E;
    Am J Respir Crit Care Med; 2013 May; 187(10):1091-7. PubMed ID: 23525934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of oral fludrocortisone in septic shock.
    Polito A; Hamitouche N; Ribot M; Polito A; Laviolle B; Bellissant E; Annane D; Alvarez JC
    Br J Clin Pharmacol; 2016 Dec; 82(6):1509-1516. PubMed ID: 27416887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
    Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ;
    JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial.
    Asehnoune K; Seguin P; Allary J; Feuillet F; Lasocki S; Cook F; Floch H; Chabanne R; Geeraerts T; Roger C; Perrigault PF; Hanouz JL; Lukaszewicz AC; Biais M; Boucheix P; Dahyot-Fizelier C; Capdevila X; Mahe PJ; Le Maguet P; Paugam-Burtz C; Gergaud S; Plaud B; Constantin JM; Malledant Y; Flet L; Sebille V; Roquilly A;
    Lancet Respir Med; 2014 Sep; 2(9):706-16. PubMed ID: 25066331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of hydrocortisone versus methylprednisolone on clinical outcomes in oncology patients with septic shock.
    McDonnell E; Collins R; Hernandez M; Brown ART
    J Oncol Pharm Pract; 2021 Jan; 27(1):54-62. PubMed ID: 32686618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.
    Keh D; Trips E; Marx G; Wirtz SP; Abduljawwad E; Bercker S; Bogatsch H; Briegel J; Engel C; Gerlach H; Goldmann A; Kuhn SO; Hüter L; Meier-Hellmann A; Nierhaus A; Kluge S; Lehmke J; Loeffler M; Oppert M; Resener K; Schädler D; Schuerholz T; Simon P; Weiler N; Weyland A; Reinhart K; Brunkhorst FM;
    JAMA; 2016 Nov; 316(17):1775-1785. PubMed ID: 27695824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steroids in sepsis--more effective than activated protein C?
    Bradley C
    Intensive Crit Care Nurs; 2001 Aug; 17(4):242-4. PubMed ID: 11868733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost-effectiveness of adjunctive corticosteroids for patients with septic shock.
    Thompson KJ; Taylor CB; Venkatesh B; Cohen J; Hammond NE; Jan S; Li Q; Myburgh J; Rajbhandari D; Saxena M; Kumar A; Finfer SR;
    Crit Care Resusc; 2020 Sep; 22(3):191-199. PubMed ID: 32900325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrocortisone Compared with Placebo in Patients with Septic Shock Satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion Criteria: A Post Hoc Analysis of the ADRENAL Trial.
    Venkatesh B; Finfer S; Cohen J; Rajbhandari D; Arabi Y; Bellomo R; Billot L; Glass P; Joyce C; Li Q; McArthur C; Perner A; Rhodes A; Thompson K; Webb S; Myburgh J
    Anesthesiology; 2019 Dec; 131(6):1292-1300. PubMed ID: 31651531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the effectiveness and safety of hydrocortisone therapy in cancer patients with septic shock.
    Nazer L; AlNajjar T; Al-Shaer M; Rimawi D; Hawari F
    J Oncol Pharm Pract; 2015 Aug; 21(4):274-9. PubMed ID: 24781452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hydrocortisone-fludrocortisone combination on mortality in septic shock: a systematic review and meta-analysis.
    Wu JY; Liu MY; Liu TH; Huang PY; Restinia M; Hsu WH; Tsai YW; Chuang MH; Hung KC; Lai CC
    Infection; 2024 Aug; ():. PubMed ID: 39192056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.